Navigation Links
Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Date:9/11/2007

ACTOS. ACTOS can cause or worsen congestive heart failure. Talk to your doctor immediately if you experience rapid weight gain, fluid retention, or shortness of breath.

Do not take ACTOS if you have active liver disease. Your doctor should perform a blood test to check for liver problems before you start ACTOS and periodically thereafter. Talk to your doctor immediately if you experience nausea, vomiting, stomach pain, tiredness, loss of appetite, dark urine, or yellowing of the skin. If you are of childbearing age, talk to your doctor before taking ACTOS, as it could increase your chance of becoming pregnant. Some people taking ACTOS may experience flulike symptoms, mild-to-moderate swelling of legs and ankles, and anemia. When taking ACTOS with insulin or sulfonylureas, you may be at risk for low blood sugar. Patients with diabetes should have regular eye exams. If you experience vision problems, consult your doctor immediately. Very rarely, some patients have experienced visual changes while taking ACTOS.

Please visit the ACTOS Web site at http://www.actos.com for Complete Prescribing Information.

Takeda Pharmaceuticals North America, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc., is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. In the United States, Takeda currently markets oral diabetes, insomnia, and gastroenterology treatments, and through Takeda Global Research & Development Center, Inc., the company has a robust pipeline with compounds in development for diabetes, cardiovascular disease, and other conditions. Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. To learn more about the company and its products, visit http://www.tpna.com.

ACTOS(R) (piogl
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab
2. Largest Ever Study of Genetics Behind Common Diseases Published
3. A Just Published Book Promises To Guide Women Regarding Their Frequent UTI’
4. Findings on Dangerous Parasite, Toxoplasma Gondii Published
5. Siddha Medicine Texts to Be Published in English
6. Journal Recommends How To Improve The Performance Of Health Workers
7. Medical Journals should create awareness on Child survival
8. A journal’s report on stress, among pregnant wome
9. Canadian Medical Association Journals Editorial Mess Gets Murkier
10. Journalists Blamed For Bird Flu Spread Across Israel
11. Future of Canadian Medical Association Journal Threatened

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...., Nov. 9 - The U.S. Cen...ntly awarded the Pennsylvania Coalition Against Ra...o continue funding its National Sexual Violence Re...he NSVRC since 2000 to serve as the nation,s princ...g, and sharing information and resources about all...
(Date:11/9/2009)... Madeleines to the overbearing food critic in the ...ildhood at the aroma of stew, artists have long be...trong memories. Scientists at the Weizmann Institu...is of this connection. Their research appeared in ...te student Yaara Yeshurun, together with Profs. No...
(Date:11/9/2009)...those hurt are under 16, researchers say , ...juries have skyrocketed in the United States in re... 2007, a new study has found. , However, the t...ategory that includes whirlpools and spas -- remai...ut half of the injuries were caused by slips and f...
(Date:11/9/2009)..., Nov. 9 Renewal Laboratories anno... process to produce functional beverages with impo...al, nutritionally important supplements such as Co...ow be offered in appealing and refreshing drinks. ... of all natural drinks that can help maintain card...
(Date:11/9/2009)... On Tuesday November 10th, at 5:30 pm CS...g a lecture on Radiation Therapy Options for Mesot...ia teleconference, and via the mesocare.org websit...s) November 9, 2009 -- Mesothelioma lecture on T...org is sponsoring a lecture by Veronica Garza of M...
Breaking Medicine News(10 mins):Health News:CDC Awards Vital Prevention Funding to National Sexual Violence Resource Center 2Health News:Sniffing out memories 2Health News:Hot-Tub Injuries on the Rise 2Health News:Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health 2
...vival increase according to stage of disease, a ne... issue of CANCER, a peer-reviewed journal of the A...f survival data demonstrates that within each stag...inical factors the racial disparities in survival ...
...ditorial, to be published in the international jou...sevierhealth.com/journals/joca/ ), published by El...recommended that coxibs and nonsteroidal anti-infl...an international workshop organized by the Osteoar...
...en a routine visit to the family doctor includes a...ing Alzheimer’s disease (AD). If the test returns ...ns that might begin to gum up memory and thought i...hers at Mayo Clinic’s campus in Jacksonville aims ...
...ts who do not respond to traditional therapy can b...l transplant, according to an Indiana University S...he New England Journal of Medicine. About 90 p...tment of this disease by Lawrence Einhorn, M.D., a...
...eached 'epidemic' levels for the second time in th...ay said. The Ministry of Health said 381 ...the 'epidemic threshold' of 378 cases per week. ... ministry said. Singapore experienced its ...
...rth of the first baby to be produced from an egg, ... and defrosted for later use. The news pr...failure or who cannot be administered drugs that h...ductive Centre in Montreal. The baby's mother has ...
Other Medicine News:Health News:Survival differences by race most apparent in advanced stages of breast cancer 2Health News:Using coxibs and NSAIDs to treat osteoarthritis 2Health News:A new century of Alzheimer's disease research 2Health News:A new century of Alzheimer's disease research 3Health News:A new century of Alzheimer's disease research 4Health News:A new century of Alzheimer's disease research 5Health News:A new century of Alzheimer's disease research 6Health News:A new century of Alzheimer's disease research 7Health News:A new century of Alzheimer's disease research 8Health News:A new century of Alzheimer's disease research 9Health News:A new century of Alzheimer's disease research 10Health News:A new century of Alzheimer's disease research 11Health News:A new century of Alzheimer's disease research 12Health News:A new century of Alzheimer's disease research 13Health News:A new century of Alzheimer's disease research 14Health News:A new century of Alzheimer's disease research 15Health News:A new century of Alzheimer's disease research 16Health News:A new century of Alzheimer's disease research 17Health News:Advanced therapy offers cure for relapsed cancer patient 2Health News:First Baby Born from Eggs Matured and Frozen in the Lab 2
(Date:11/9/2009)... 9 Bend Research Inc., a company,w...nnovative pharmaceutical,technologies to help clie...nical problems, announced today that it has entere... Incorporated, a global biotechnology company,head...s new collaboration, Vertex will utilize Bend,s fo...
(Date:11/8/2009)...e of Health Care Reform Bill ,, Critical legi...e for all Americans ,, BOISE, Idaho, Nov. 7 ... House of Representatives passed critical health c...are for seniors and end discrimination by insuranc...of affordable health coverage. ,, The Afforda...
(Date:11/6/2009)...ire-FirstCall/ -- Recession in domestic and intern...ied Healthcare Products in the first quarter of fi...les declines pushed Allied into a loss for the qua...,000, or negative 9 cents per share, compared to a... 3 cents per share. ,, Sales fell about 21 per...
Breaking Medicine Technology:Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Smart for Life 28TM 29 Featured in Womans World Magazine 51752 1Smart for Life 28TM 29 Featured in Womans World Magazine 51752 2Oncolytics Biotech 28R 29 Inc Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting 13038 1Oncolytics Biotech 28R 29 Inc Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting 13038 2Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 1Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 2Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 3
...lts at 2007 American Association for,Cancer Resear...wswire-FirstCall/ -- Cleveland,BioLabs, Inc. , ann... CBLB502,s efficacy as a mitigator of both,gastroi...d,production) radiation-induced damage in non-huma..., Andrei Gudkov, Ph.D, D. Sci.,will present resul...
...ESS WIRE)--Apr 9, 2007 -,GlaxoSmithKline (LSE and ...ay announced data from Study 767905/014 and,provid...or,alvimopan (Entereg/Entrareg(R))., Study 014, a ...h) study, was designed to evaluate the long-term s...aily in patients taking,opioids for chronic non-ca...
Other Medicine Technology:Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 2Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 2GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 4GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 5GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 6GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 7
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: